The Business Research Company’s report on the Single Nucleotide Polymorphism (SNP) Genotyping Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
Which emerging drivers are set to accelerate the growth of the single nucleotide polymorphism (snp) genotyping market further?
The increasing burden of chronic conditions is expected to propel the growth of the single nucleotide polymorphism (SNP) genotyping market going forward. Chronic conditions are problems that last a year or longer, necessitating continuing medical care, restricting everyday activities, or both. Single-nucleotide polymorphism (SNP) genotyping is essential for identifying genetic predispositions and promoting personalized medicine due to the increased prevalence of chronic diseases. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, the death rate linked to chronic conditions rose from 459 deaths per 100,000 people in 2021 to 490 deaths per 100,000 people in 2022. Therefore, the increasing burden of chronic conditions drives the growth of the single nucleotide polymorphism (SNP) genotyping systems market.
Access Your Free Sample of the Global Single Nucleotide Polymorphism (SNP) Genotyping Market Report – Get Insights Now!
Single Nucleotide Polymorphism (SNP) Genotyping Market Report 2025 Sample
What are the key factors influencing the forecasted market size of the single nucleotide polymorphism (snp) genotyping industry?
The single nucleotide polymorphism (SNP) genotyping market size has grown exponentially in recent years. It will grow from $10.3 billion in 2024 to $12.37 billion in 2025 at a compound annual growth rate (CAGR) of 20.1%. The growth in the historic period can be attributed to increasing research in genomics, rise in genetic disorders, growth in personalized medicine, expanding pharmaceutical industry, and rising demand for molecular diagnostics
The single nucleotide polymorphism (SNP) genotyping market size is expected to see rapid growth in the next few years. It will grow to $24.95 billion in 2029 at a compound annual growth rate (CAGR) of 19.2%. The growth in the forecast period can be attributed to growing applications in disease research, a rise in demand for precision medicine, expanding biobanking initiatives, the surge in genetic testing, and rising adoption in agriculture for crop improvement. Major trends in the forecast period include increasing use of next-generation sequencing (NGS), rising demand for SNP genotyping in pharmacogenomics, the emergence of direct-to-consumer genetic testing, focus on automation, and high-throughput genotyping platforms.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
Single Nucleotide Polymorphism (SNP) Genotyping Market Report 2025 Customise
Who are the leading competitors in the single nucleotide polymorphism (snp) genotyping market?
Major companies operating in the single nucleotide polymorphism (SNP) genotyping market include Thermo Fischer Scientific Inc., Danaher Corporation, Roche Diagnostics Corporation, GE HealthCare Technologies Inc., Eurofins Genomics LLC, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Sigma-Aldrich Corporation, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Promega Corporation, GenScript Biotech Corporation, Integrated DNA Technologies Inc., LGC Ltd., Sequenom Inc., Fluidigm Corporation, Agendia Inc., Nugen Technologies Inc., BioChain Institute Inc., Standard BioTools Inc., Oxford Gene Technology, Affymetrix Inc., PREMIER Biosoft International Inc., GenoLogics, Rubicon Genomics Inc., Xcelris Genomics, Douglas Scientific LLC, Golden Helix Inc.
Which emerging trends are set to transform the single nucleotide polymorphism (snp) genotyping market landscape?
Technological solutions are a key trend gaining popularity in the single nucleotide polymorphism (SNP) genotyping market. Major companies operating in the single nucleotide polymorphism (SNP) genotyping market are introducing technologically advanced solutions to sustain their position in the market. For instance, in May 2022, Neogen Corporation, a US-based food safety company that provides solutions for the agriculture, animal protein, food, and beverage industries, and Gencove, a US-based provider of sequencing solutions, launched InfiniSEEK. It is the first complete genome and genotyping tool for cattle breeders. InfiniSEEK’s thorough validation shows that low-pass genome-wide sequencing is more than 99% concordant with deep whole-genome sequencing and can provide even higher clinical-grade accuracy in some areas of interest.
How do different geographies compare in terms of market share and growth potential in the single nucleotide polymorphism (snp) genotyping market?
North America was the largest region in the single nucleotide polymorphism (SNP) genotyping market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single nucleotide polymorphism (SNP) genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Order Your Report Now For Swift Delivery
Single Nucleotide Polymorphism (SNP) Genotyping Market Report 2025
Which major segments of the single nucleotide polymorphism (snp) genotyping market are experiencing the fastest growth?
The single nucleotide polymorphism (SNP) genotyping market covered in this report is segmented –
1) By Product: Consumables, Instruments, Services
2) By Technology: TaqMan SNP Genotyping, Mass Array SNP Genotyping, SNP Gene Chip Arrays, Other Technologies
3) By Application: Animal Genetics, Plant Improvement, Diagnostic Research, Pharmaceuticals And Pharmacogenomics, Agricultural Biotechnology, Other Applications
Subsegments:
1) By Consumables: Reagents And Kits, DNA Probes, Microarrays
2) By Instruments: SNP Genotyping Platforms, Sequencers, PCR Machines
3) By Services: SNP Genotyping Services, Data Analysis Services, Consultation Services
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
Single Nucleotide Polymorphism (SNP) Genotyping Market Report 2025
How is the single nucleotide polymorphism (snp) genotyping market defined, and what are its core characteristics?
Single nucleotide polymorphism (SNP) genotyping refers to a procedure that locates and describes genetic variants at the level of specific DNA nucleotides. It identifies individual SNPs, which are single-base changes in DNA sequences, and it is essential for understanding the genetic variations linked to diseases, traits, and population studies.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
